Medistim ASA
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Medistim ASA generated cash of $113,189,000, which is less than the previous year. Cash used in financing activities reached the amount of -$84,883,000 last year. Net change in cash is therefore $1,231,000.
Cash Flow
| 2014 | 48.93M | -14.46M | -4.68M |
|---|---|---|---|
| 2015 | 44.65M | -11.77M | -31.54M |
| 2016 | 30.47M | -13.45M | -34.34M |
| 2017 | 60.10M | -14.48M | -21.47M |
| 2018 | 55.79M | -16.37M | -44.73M |
| 2019 | 80.38M | -13.68M | -46.89M |
| 2020 | 74.13M | -10.63M | -58.34M |
| 2021 | 128.13M | -11.48M | -59.05M |
| 2022 | 113.49M | -21.10M | -70.30M |
| 2023 | 113.18M | -29.72M | -84.88M |
MEDI.OL Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 152.64M | 129.49M | 71.89M | 66.74M | 47.49M | 54.41M | 31.06M | 48.92M | 49.47M | 19.84M |
Operating activities | ||||||||||
Net income | 103.82M | 113.97M | 90.9M | 69.38M | 70.30M | 57.05M | 47.57M | 39.09M | 40.42M | 31.24M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 23.65M | 23.28M | 23.42M | 23.14M | 18.01M | 12.36M | 13.22M | 11.72M | 13.38M | 8.26M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 27.35M | -33.02M | -11.14M | 4.70M | 8.61M | -15M | -7.47M | -3.49M | -4.88M | -1.16M |
Inventories | -31.05M | -16.92M | 15.25M | -22.59M | -26.22M | -1.12M | -3.42M | -12.68M | -9.73M | 1.05M |
Accounts payable | 613K | 11.26M | -324K | -1.29M | 2.89M | -1.58M | 5.08M | -4.29M | 4.26M | 0 |
Cash generated by operating activities | 113.18M | 113.49M | 128.13M | 74.13M | 80.38M | 55.79M | 60.10M | 30.47M | 44.65M | 48.93M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -16.39M | -21.10M | -11.48M | -10.63M | -13.68M | -16.37M | -14.48M | -13.45M | -11.77M | -14.46M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -29.72M | -21.10M | -11.48M | -10.63M | -13.68M | -16.37M | -14.48M | -13.45M | -11.77M | -14.46M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 561K | 1.02M | 900K | 0 |
Payments for dividends | -82.18M | -68.39M | -54.64M | -50.05M | -40.92M | -36.35M | -31.78M | -29.95M | -25.36M | -14.48M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -4.5M | -3M | -3M | -4.87M | 9.75M | -5.41M | -7.08M | -5.20M |
Cash used in financing activities | -84.88M | -70.30M | -59.05M | -58.34M | -46.89M | -44.73M | -21.47M | -34.34M | -31.54M | -4.68M |
Net Change In Cash | 1.23M | 23.15M | 57.59M | 5.14M | 19.25M | -6.92M | 23.34M | -17.86M | -550K | 29.62M |
Cash at end of period | 153.87M | 152.64M | 129.49M | 71.89M | 66.74M | 47.49M | 54.41M | 31.06M | 48.92M | 49.47M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |